Efficacy and Safety of Intravitreal Aflibercept Treat-And-Extend Regimens in Exudative Age-Related Macular Degeneration: 52- And 96-Week Findings From ALTAIR
Advances in Therapy - United States
doi 10.1007/s12325-020-01236-x
Full Text
Open PDFAbstract
Available in full text
Date
February 3, 2020
Authors
Publisher
Springer Science and Business Media LLC